CNS Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
/ 
Frequently asked questions
To buy CNS Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CNS Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CNS Pharmaceuticals Inc. is CNSP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CNS Pharmaceuticals Inc. has its primary listing on NASDAQ (Small cap). You can trade CNS Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CNS Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CNS Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CNS Pharmaceuticals Inc..